Methylphenidate extended-release oral suspension - Tris Pharma
At a glance
- Drug Originator NextWave Pharmaceuticals
- Drug Licenced by KYE Pharmaceuticals; Medison Pharma; Neuraxpharm; Pediatrix Therapeutics
- Drug Class Behavioural disorder therapies; Neuroprotectants; Nootropics; Phenylacetates; Piperidines; Sleep disorder therapies; Small molecules
- Mechanism of Action Central nervous system stimulants; Dopamine uptake inhibitors; Monoamine oxidase inhibitors
- USA Patent Applicants NEXTWAVE
- USA Patents 13
- NDAs 1
- International Patents 30
- Patent Applications 3,514

Disclaimer